Multidisciplinary intensive lifestyle intervention improves markers of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes and obesity: a retrospective matched-cohort study

[1]  J. Machann,et al.  Liver fat scores do not reflect interventional changes in liver fat content induced by high-protein diets , 2021, Scientific Reports.

[2]  Sangam Rajak,et al.  Current treatment paradigms and emerging therapies for NAFLD/NASH. , 2021, Frontiers in bioscience.

[3]  A. Mangia,et al.  Noninvasive Diagnosis of NAFLD and NASH , 2020, Cells.

[4]  Rachel J. Perry,et al.  Novel Strategies to Treat Hepatic Steatosis and Steatohepatitis , 2019, Obesity.

[5]  A. Ezzat,et al.  Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis , 2019, Diabetes, metabolic syndrome and obesity : targets and therapy.

[6]  E. Bugianesi,et al.  NASH in Lean Individuals , 2019, Seminars in Liver Disease.

[7]  A. Pfeiffer,et al.  Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet , 2018, Nutrients.

[8]  V. Pīrāgs,et al.  Fatty liver index and hepatic steatosis index for prediction of non‐alcoholic fatty liver disease in type 1 diabetes , 2018, Journal of gastroenterology and hepatology.

[9]  Michael Charlton,et al.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.

[10]  J. Coombes,et al.  NAFLD in clinical practice: Can simple blood and anthropometric markers be used to detect change in liver fat measured by 1H‐MRS? , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[11]  M. Schulze,et al.  An extended fatty liver index to predict non-alcoholic fatty liver disease. , 2017, Diabetes & metabolism.

[12]  O. Hamdy,et al.  Long-term effect of intensive lifestyle intervention on cardiovascular risk factors in patients with diabetes in real-world clinical practice: a 5-year longitudinal study , 2017, BMJ Open Diabetes Research and Care.

[13]  G. Lippi,et al.  Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes. , 2016, International journal of cardiology.

[14]  V. Mohan,et al.  Clinical profile of nonalcoholic Fatty liver disease among young patients with type 1 diabetes mellitus seen at a diabetes speciality center in India. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[15]  C. Hellerbrand,et al.  Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. , 2014, Best practice & research. Clinical gastroenterology.

[16]  E. Bonora,et al.  Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes , 2014, Diabetes Care.

[17]  D. Benaiges,et al.  Type 1 diabetes, metabolic syndrome and cardiovascular risk. , 2014, Metabolism: clinical and experimental.

[18]  G. Targher,et al.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis , 2013, Nature Reviews Gastroenterology &Hepatology.

[19]  E. Bonora,et al.  Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. , 2010, Journal of hepatology.

[20]  H. Kim,et al.  Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[21]  O. Hamdy,et al.  The why WAIT program: Improving clinical outcomes through weight management in type 2 diabetes , 2008, Current diabetes reports.

[22]  A. Campbell.  Tackling "diabesity" head-on. Joslin Diabetes Center's new nutrition guideline. , 2005, Diabetes self-management.

[23]  T. Roskams,et al.  Cirrhosis reversal: a duel between dogma and myth. , 2004, Journal of hepatology.

[24]  A. Veves,et al.  Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. , 2003, Diabetes care.

[25]  Z. Younossi,et al.  Non‐alcoholic fatty liver disease: An overview , 2002, Journal of gastroenterology and hepatology.

[26]  N. Alkhouri,et al.  The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients , 2018, Hepatology International.

[27]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..